CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 25K 50K 75K Q3 '21: 10K Q4 '21: 67.8K Q1 '22: 15K Q2 '22: 0 Q3 '22: 55K Q4 '22: 18.6K Q1 '23: 0 Q2 '23: 0 Q3 '23: 6K Q4 '23: 3K Q1 '24: 0 Q2 '24: 8K Q3 '24: 0 Q4 '24: 3K Q1 '25: 3K Q2 '25: 0 Q3 '25: 0 Q4 '25: 3K Q1 '26: 0 Q2 '26: 0 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 15K 30K 45K Q3 '21: 6K Q4 '21: 28.3K Q1 '22: 8.2K Q2 '22: 0 Q3 '22: 39K Q4 '22: 12.9K Q1 '23: 0 Q2 '23: 0 Q3 '23: 3.6K Q4 '23: 1.8K Q1 '24: 0 Q2 '24: 4.8K Q3 '24: 0 Q4 '24: 1.8K Q1 '25: 1.8K Q2 '25: 0 Q3 '25: 0 Q4 '25: 2K Q1 '26: 0 Q2 '26: 0 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -833.4K Q4 '21: -1.5M Q1 '22: -1.2M Q2 '22: -1.8M Q3 '22: -1M Q4 '22: -6.3M Q1 '23: -1.1M Q2 '23: -1.2M Q3 '23: -1.5M Q4 '23: -1.8M Q1 '24: -1.1M Q2 '24: -1.6M Q3 '24: -1.1M Q4 '24: -1.9M Q1 '25: -1.7M Q2 '25: -1.3M Q3 '25: -1.3M Q4 '25: -1.9M Q1 '26: -1.5M Q2 '26: -1.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -1.8M Q4 '21: -3.9M Q1 '22: -1.2M Q2 '22: -1.8M Q3 '22: -982.3K Q4 '22: -6.2M Q1 '23: -1.1M Q2 '23: -1.1M Q3 '23: -1.5M Q4 '23: -1.7M Q1 '24: -1M Q2 '24: -1.6M Q3 '24: -1M Q4 '24: -1.9M Q1 '25: -1.6M Q2 '25: -1.2M Q3 '25: -1.2M Q4 '25: -1.9M Q1 '26: -1.4M Q2 '26: -1.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 15K 30K 45K Q3 '21: 4K Q4 '21: 39.4K Q1 '22: 6.8K Q2 '22: 0 Q3 '22: 16K Q4 '22: 5.7K Q1 '23: 0 Q2 '23: 0 Q3 '23: 2.4K Q4 '23: 1.2K Q1 '24: 0 Q2 '24: 3.2K Q3 '24: 0 Q4 '24: 1.2K Q1 '25: 1.2K Q2 '25: 0 Q3 '25: 0 Q4 '25: 994 Q1 '26: 0 Q2 '26: 0 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -390.8K Q4 '21: -1.2M Q1 '22: -1.6M Q2 '22: -1.8M Q3 '22: -873.3K Q4 '22: -3.6M Q1 '23: -3.8M Q2 '23: -986.7K Q3 '23: -1.3M Q4 '23: -1.9M Q1 '24: -896.9K Q2 '24: -1.5M Q3 '24: -985.6K Q4 '24: -1.9M Q1 '25: -1.6M Q2 '25: -1.2M Q3 '25: -1.2M Q4 '25: -1.9M Q1 '26: -1.3M Q2 '26: -1.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 600M 1.2B 1.8B Q1 '19: 6.4M Q2 '19: 7.1M Q3 '19: 1.5B Q1 '20: 776.6M Q2 '20: 169.2M Q3 '20: 2.5M Q1 '21: 1.2B Q2 '21: 2.3M Q3 '21: 2.5M Q1 '22: 6.5M Q2 '22: 9M Q3 '22: 14.1M Q1 '24: 1.4M Q2 '24: 1.4M Q3 '24: 1.4M Q1 '25: 2M Q2 '25: 2.6M Q3 '25: 2.6M Q1 '26: 3.7M Q2 '26: 3.7M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-75.00 -50.00 -25.00 0.00 25.00 50.00 75.00 Q4 '18: -3.52 Q1 '19: -3.60 Q2 '19: -3.60 Q3 '19: -3.60 Q4 '19: -0.95 Q1 '20: -0.83 Q2 '20: -0.83 Q3 '20: -0.69 Q4 '20: -63.63 Q1 '22: -5.75 Q2 '22: -4.70 Q3 '22: -4.02 Q4 '22: -0.98 Q4 '24: -2.25 Q1 '25: -3.81 Q2 '25: -3.18 Q3 '25: -2.91 Q4 '25: -2.59 Q1 '26: -2.14 Q2 '26: -2.07 Q1 '19 Q4 '19 Q3 '20 Q2 '22 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.